Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Nov;83(11):2347-2355.
doi: 10.1111/bcp.13350. Epub 2017 Aug 11.

Comparison of effect sizes between enriched and nonenriched trials of analgesics for chronic musculoskeletal pain: a systematic review

Tie P Yamato  1 , Chris G Maher  1 , Bruno T Saragiotto  1 , Christina Abdel Shaheed  1 , Anne M Moseley  1 , Chung-Wei Christine Lin  1 , Bart Koes  2 , Andrew J McLachlan  3
Affiliations
Meta-Analysis

Comparison of effect sizes between enriched and nonenriched trials of analgesics for chronic musculoskeletal pain: a systematic review

Tie P Yamato et al. Br J Clin Pharmacol. 2017 Nov.

Abstract

Aims: To investigate the use of an enriched study design on the estimates of treatment effect in analgesic trials for chronic musculoskeletal pain.

Methods: Database searches were conducted from 2004 to 2014. We included randomized placebo-controlled trials evaluating pain medications for chronic musculoskeletal pain. Methodological quality was assessed using the PEDro scale. The estimates of treatment effect on pain and adverse events were compared between enriched and nonenriched designs. Metaregression was used to assess the association between the effect size estimate and the study design controlling for analgesic dose and methodological quality.

Results: We included 108 trials, of which 99 were included in the meta-analysis (n = 44 171). There were no overall differences in effect sizes between enriched and nonenriched designs for pain intensity. There was a significant difference for a reduction in any adverse events favouring enriched designs for opioids, but not for other analgesics or the outcome serious adverse events. There was an association between effect size and methodological quality, with failure to blind the outcome assessor and failure to use intention-to-treat analysis being associated with larger effect sizes.

Conclusions: There is no evidence that the use of an enriched study design changes the treatment effect size estimate for pain. There is some evidence that clinical trials that employ enriched designs report a reduced risk of adverse events in trials for chronic musculoskeletal pain, but it is unclear whether enriched designs influence estimates of serious adverse events. Features of trial design and study quality were associated with treatment effect estimates.

Keywords: analgesics; chronic pain; methodology; opioids.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of the inclusion process of the study
Figure 2
Figure 2
Difference in the effect estimates between enriched and nonenriched designs for pain intensity
Figure 3
Figure 3
Difference in the effect estimates between enriched and nonenriched designs for any or serious adverse events
See this image and copyright information in PMC

References

    1. Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet 2014; 383: 166–175. - PMC - PubMed
    1. Straube S, Derry S, McQuay HJ, Moore RA. Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review. Br J Clin Pharmacol 2008; 66: 266–275. - PMC - PubMed
    1. Furlan A, Chaparro LE, Irvin E, Mailis‐Gagnon A. A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain. Pain Res Manag 2011; 16: 337–351. - PMC - PubMed
    1. Katz N. Enriched enrollment randomized withdrawal trial designs of analgesics: focus on methodology. Clin J Pain 2009; 25: 797–807. - PubMed
    1. Lemmens HJ, Wada DR, Munera C, Eltahtawy A, Stanski DR. Enriched analgesic efficacy studies: an assessment by clinical trial simulation. Contemp Clin Trials 2006; 27: 165–173. - PubMed